Opdivo may bring survival boost for lung cancer patients
Lifelong smoker Mike James had quit the habit for nearly three years when, through fluky circumstances, he found out that he had a small tumor in his right lung.
Apr 14, 2022
0
5
Lifelong smoker Mike James had quit the habit for nearly three years when, through fluky circumstances, he found out that he had a small tumor in his right lung.
Apr 14, 2022
0
5
Preliminary data from an artificial intelligence model could potentially predict side effects resulting from new combination therapies, according to results presented at the AACR Annual Meeting 2022, held April 8-13.
Apr 8, 2022
0
26
Scientists have created a prototype test that can predict which drug combinations are likely to work for cancer patients in as little as 24 to 48 hours.
Apr 4, 2022
0
17
"COVID has created an unprecedented public health crisis, with severe effects on the global economy and infrastructure; however, we can use the power of science to stop this pandemic," says Columbia team leader Jingyue Ju, ...
Mar 7, 2022
0
9
An immunotherapy drug called pembrolizumab has been shown to significantly reduce disease recurrence in patients with the most aggressive type of breast cancer, according to results from a phase III clinical trial led by ...
Feb 10, 2022
0
13
When you open a carton of Neapolitan ice cream, how do you scoop? Maybe you grab some chocolate and strawberry together, or maybe you eat one flavor at a time. The three flavors are in there to satisfy the variation you need ...
Jan 17, 2022
0
3
As the latest coronavirus variant upends expectations about the pandemic's coming months, drug manufacturers are working to expand treatment options to fight those stricken with severe disease. Even as new pills from Pfizer ...
Dec 14, 2021
0
2
A drug combination can safely prevent transplanted stem cells (graft) from attacking the recipient's (host) body, allowing them to develop into healthy new blood and immune cells, a new study shows.
Dec 13, 2021
0
49
More people with advanced melanoma survive for two years or more when they receive a combination of two immunotherapy drugs given before a combination of two targeted therapies, if needed, compared to people who start treatment ...
Nov 15, 2021
0
10
Scientists have proposed a modeling framework which could predict how antibiotic resistance will evolve in response to different treatment combinations, according to a study published in eLife.
Jul 27, 2021
0
94